Versant Venture Capital VI, L.P.

Holdings History for Monte Rosa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (GLUE)

Symbol: GLUE on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 2,236,708 shares
Security Ownership %: 3.4%

Versant Venture Capital VI, L.P. ownership in Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share (GLUE)

09 Jan 2026 - Versant Venture Capital VI, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,236,708 shares of Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share (GLUE). This represents 3.4% ownership of the company. In their previous filing dated 12 Nov 2025, Versant Venture Capital VI, L.P. had reported owning 3,334,669 shares, indicating a decrease of +33%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Versant Venture Capital VI, L.P.	3.4%	-34%	$35,080,976	2,236,708	-1,097,961	-33%	$15.68	13D/A	07 Jan 2026	09 Jan 2026, 16:19
Versant Venture Capital VI, L.P.	5.1%		$24,709,897	3,334,669			$7.41	13D/A	10 Nov 2025	12 Nov 2025, 16:13